Publications 2003

  1. Validity of self-reported prescription drug insurance coverage. Health Reports 2003;14(2):1-12. Grootendorst P, Newman EC, Levine MAH.
  2. Drug Herb Interaction Among Commonly Used Conventional Medicines: A Compendium for Health Care Professionals. Am J Ther 2003;10(3):163-9. Brazier N, Levine MAH.
  3. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. J Hypertens 2003:21:1591-1597. Campbell NRC, McAlister F, Brant R, Levine M, Drouin D, Feldman R, Herman R, Zarnke K.
  4. Understand drug-herb interactions. Pharmacoepidemiology and Drug Safety 2003;12:427-430. Brazier NC, Levine MAH.
  5. Bereavement adjustment and support among caregivers Journal of Mental Health and Aging, 2003, 9(3), 193-204. Brazil K. Bedard M., Willison K
  6. Perceptions of resident behavior problems and their clinical management in long term care facilities. Journal of Mental Health and Aging, 2003, 9(1), 35-42. Brazil K, Hasler A, McAiney C, Sturdy-Smith, Tettman M.
  7. Optimizing research on end of life care for seniors, Geriatrics Today, 2003, Vol.6(3), 173-176. Allard P, Brajman S, Brazil K, Guirguis-Yonger M, Legault F, McPherson C, Keeley M.L., Wilson K, Bond J, Chambers L, Kozak J MacLean M, Ross M, Gagnon P.
  8. Caregiving and its impact on families of the terminally ill. Aging and Mental Health, 2003, 7(5), 376-382. Brazil K. Bedard M. Willison K.
  9. Osteltamivir for treatment of influenza in health adults: pooled trial evidence and cost-effectiveness model for Canada. Value in Health, 2003; 6(2): 116-125. O’Brien B., Goeree R., Blackhouse G., Smieja M., Loeb M.
  10. Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease. Canadian Journal of Gastroenterology, 2003; 17(5): 307-312. Pare P., Meyer F., Armstrong D., Pyzyk M., Pericak D., Goeree R.
  11. Cost-effectiveness modelling in rheumatology: toward principles of good practice. Journal of Rheumatology, 2003; 30(68)Suppl:21-2. Goeree R., O’Brien B.
  12. Methods for patient-level costing in the VA system: Are they applicable to Canada? Medical Care Research and Review, 2003;60(3) Suppl to September 2003:142S-145S. Blackhouse G., Goeree R., O’Brien BJ.
  13. Efficacy and Cost-Effectiveness of the First Generation of HIV Prevention Interventions for People with Severe and Persistent Mental Illness. The Journal of Mental Health Policy and Economics; 2003; 6:23-35. Johnson-Masotti AP. Weinhardt, LS, Pinkerton SD, Otto-Salaj LL.
  14. Modeling cost-effectiveness of HIV prevention programs. Expert Rev. Pharmacoeconomics Outcomes Res. 2003; Volume 3(4):409-425. Johnson-Masotti AP.
  15. Review of economic evaluations of radiofrequency catheter ablation for cardiac arrhythmias. Can J Cardiol 2003;19(11):1285-1304. Marshall D, O’Brien BJ, Nichol, G.
  16. Increase in Statins Newly Dispensed to Ontario Seniors Between 1994 and 2000. Can J Cardiol 2003;19(6):665-669. Levy AR, O’Brien BJ, McMullen E, May FW, Demers C, Marshall D, MacLeod S. Rapid
  17. Health technology assessment, research and implementation within a health region in Alberta, Canada. International Journal of Technology Assessment in Health Care 2003;19(3):513-520. Lee RC, Marshall D, Waddell C, Hailey D, Juzwishin D.
  18. The Inverse Student-t Distribution and Its Applications in Bayesian Prediction Under the Inverse Normal Model. Journal of Statistical Theory and Applications 2003;2(3,4):235-246. Thabane L, Kibria BMG.
  19. A Closer Look at the Distribution of the Number Needed to Treat (NNT): A Bayesian Approach. Biostatistics 2003;4:365-370. Thabane L.
  20. Hypothesis Testing for the Generalized Multivariate Modified Bessel Distribution. Journal of Multivariate Analysis 2003;86(2):360-374. Thabane L, Drekic S.
  21. Testing Linear Hypotheses with the Generalized Multivariate Modified Bessel Error Variable. Journal of Statistical Research, 2003;37(1):83-94. Thabane L, Drekic S.
  22. Clinical models to compare the safety and efficacy of inhaled corticosteroids in patients with asthma. Can Respir J 2003;10(1):27-34. Parameswaran K, Leigh R, O’Byrne PM, Kelly MM, Goldsmith CH, Hargreave FE, Dolovich M.
  23. Progressive Resistance Strengthening Exercises After Stroke: A Single-blind Randomised Controlled Trial. Arch Phys Med Rehab 2003;84(10):1433-1440. Moreland J, Goldsmith CH, Huijbregts MP, Anderson RE, Prentice DM, Brunton KB, O’Brien MA, Torresin WD.
  24. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Canadian Journal of Clinical Pharmacology 2003;10(2):67-71. Levy AR, O'Brien BJ, Sellors C, Grootendorst PV, Willison DJ.
  25. Privacy and the secondary use of data for health research. Experience in Canada, and suggested directions forward. Journal of Health Services Research and Policy 2003;8(Suppl1):17-23. Willison DJ.
  26. Patient consent preferences for research use of family physicians’ electronic medical records. Results from interviews and a survey. BMJ 2003;326(7385):373-377. Willison DJ, Keshavjee KK, Nair K, Goldsmith C, Holbrook AM.
  27. A review of the comprehensiveness of provincial drug coverage for Canadian seniors. Canadian Journal on Aging 2003;22(1):33-44. Grootendorst P, Palfrey D, Willison D, Hurley J.
  28. Innovation and placebos in research: a new design of clinical trial. Lancet 2003:362;2036-37. Holbrook A, Goldsmith C.
  29. Applying methodology to Electronic Medical Record Selection. International Journal of Medical Informatics 2003:71;43-50. Holbrook A, Keshavjee K, Troyan S, Pray M, Ford P, for the COMPETE Investigators.
  30. The challenge and importance of ensuring that patient information needs are met. (editorial) Canadian Journal of Hospital Pharmacy. 2003;56:133-135 Dolovich L.
  31. Collaboration between community pharmacists and family physicians: Lessons learned from the Seniors Medication Assessment Research Trial (SMART). Journal of the American Pharmaceutical Association. 2003;43:566-72. Howard M, Trim K, Woodward C, Dolovich L, Sellors C, Kaczorowski J, Sellors J.
  32. Randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ 2003;169:17-22 Sellors J, Kaczorowski J, Woodward C, Willan A, Sellors C, Dolovich L, Goeree R, Cosby R, Trim K, Sebaldt R, Howard M, Poston J.
  33. Providing evidence-based information to patients in general practice and pharmacies: what is the acceptability, usefulness and impacy on drug use? Health Expectations 2003; 6:281-9. McCormack JP, Dolovich L, Burns S, Levine M, Nair K, Cassels A, Mann K, Gray J.
  34. Analysis of environmental factors in familial versus sporadic Paget’s disease of bone - the New England Registry for Paget’s Disease of Bone. J Bone Miner Res 2003; 18:1519-24. Seton M, Choi HK, Hansen MF, Sebaldt RJ, Cooper C.
  35. Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database. Osteoporosis International 2003;14:808-813. Papaioannou A, Ioannidis G, Adachi, JD, Sebaldt RJ, Ferko N, Puglia M, Brown J, Tenenhouse A, Olszynski WP, Boulos P, Hanley DA, Josse R, Murray TM, Petrie A, Goldsmith CH.
  36. What predicts early fracture or bone loss on bisphosphonate therapy? J Clin Densitometry 2003; 6:315-322. Sawka AM, Adachi JD, Ioannidis G, Olszynski W, Brown JP, Hanley DA, Murray T, Josse R, Sebaldt RJ, Petrie A, Tenenhouse A, Papaioannou A, Goldsmith CH.
Toronto Web Design by LinxSmart
Graphic Design by Electra